4 results  1 of 1 

1 Assessing the Optimal Cutpoint for Tumor Size in Patients with Lung Cancer Based on Linear Rank Statistics in a Competing Risks Framework
Jinheum Kim, Hon Keung Tony Ng, Seong W. Kim
Yonsei Med J.2019;60(6):517-524.   Published online 2019 May 22     DOI: http://dx.doi.org/10.3349/ymj.2019.60.6.517
      
2 Comparison of cobas EGFR Mutation Test v2 and PANAMutyper-R-EGFR for Detection and Semi-Quantification of Epidermal Growth Factor Receptor Mutations in Plasma and Pleural Effusion Supernatant
A-Lum Han, Hak-Ryul Kim, Keum-Ha Choi, Ki-Eun Hwang, Mengyu Zhu, Yuya Huang, Moxin Wu, Young-Jin Lee, Min-Cheol Park, Ji-Hyun Cho, Do-Sim Park
Ann Lab Med.2019;39(5):478-487.   Published online 2019 April 26     DOI: http://dx.doi.org/10.3343/alm.2019.39.5.478
      
3 KRAS Mutation Test in Korean Patients with Colorectal Carcinomas: A Methodological Comparison between Sanger Sequencing and a Real-Time PCR-Based Assay
Sung Hak Lee, Arthur Minwoo Chung, Ahwon Lee, Woo Jin Oh, Yeong Jin Choi, Youn-Soo Lee, Eun Sun Jung
J Pathol Transl Med.2017;51(1):24-31.   Published online 2016 December 25     DOI: http://dx.doi.org/10.4132/jptm.2016.10.03
      
4 Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
Seung Eun Lee, So-Young Lee, Hyung-Kyu Park, Seo-Young Oh, Hee-Joung Kim, Kye-Young Lee, Wan-Seop Kim
J Korean Med Sci.2016;31(8):1224-1230.   Published online 2016 May 12     DOI: http://dx.doi.org/10.3346/jkms.2016.31.8.1224
      

 1 of 1